Enzymotec
company
About
Enzymotec is a biotechnology company developing and manufacturing nutritional ingredients and medical foods.
- Migdal Hameq,HaZafon,Israel
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $11M
- Industries
- Biotechnology,Health Care,Manufacturing
- Founded date
- Jan 1, 1998
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Stock Symbol
- nasdaq:ENZY
Enzymotec is a biotechnology company that develops and produces biofunctional ingredients to address health needs associated with the human life cycle, starting from babies up to seniors.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$95.90M
Enzymotec has raised a total of
$95.90M
in funding over 2 rounds. Their latest funding was raised on
Aug 1, 2017 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 1, 2017 | Post-IPO Equity | $12.90M | 1 |
Frutarom
|
— | Detail |
| Sep 27, 2013 | IPO | $62M | — | — | — | Detail |
| Jan 3, 2012 | Series B | $10M | 1 |
TPY Capital
|
— | Detail |
| Mar 21, 2010 | Series Unknown | — | 1 | — | — | Detail |
| Feb 2, 2009 | Series B | $11M | 4 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
7
Enzymotec is funded by 7 investors.
Frutarom
and TPY Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Frutarom
|
Yes | Post-IPO Equity |
|
TPY Capital
|
Yes | Series B |
Vintage Investment Partners
|
— | Series Unknown |
Millennium II Materials Technology Fund
|
— | Series B |
Arancia International
|
— | Series B |
Galam
|
— | Series B |
Ofer Hi-Tech
|
— | Series B |
Employee Profiles
Number of Employee Profiles
16
Enzymotec has 16 current employee profiles, including
Board member Michal Silverberg
Board member
Board member
Board member
Board member
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
